Author(s): Henderson RL
We present a case where etanercept–a soluble tumor necrosis factor receptor-Fc fusion protein-was safe and effective in treating the painful skin lesions of a 24-year-old patient with hidradenitis suppurativa, resulting in an improvement in quality of life.
Dermatology Journal and/or Publisher
Journal Name: Journal of drugs in dermatology : JDD
Journal Abbreviation: J Drugs Dermatol
Journal Date Published: 2007-03-21
National Center for Biotechnology Information
Article Source: http://www.ncbi.nlm.nih.gov/pubmed/17373153
Lasted Revision: 2015-11-19
Abstract Source: National Center for Biotechnology Information, U.S. National Library of Medicine Abstract Query for Hidradenitis suppurativa (HS).